Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth

Area of Science:

• Nephrology
• Cell Biology
• Vascular Biology

Background:

• Podocytes and glomerular endothelial cells (GEN) are key in glomerulosclerosis.
• Angiotensin inhibition is vital for chronic kidney disease (CKD) treatment, impacting blood pressure and extracellular matrix.
• Understanding angiotensin's role in podocyte-GEN interactions is crucial for CKD management.

Purpose of the Study:

• To investigate how angiotensin inhibition affects interactions between podocytes and GEN.
• To determine the impact of angiotensin type 1 receptor blockers (ARBs) on podocyte-GEN communication.
• To explore the molecular mechanisms underlying ARB-mediated effects on glomerular capillary remodeling.

Main Methods:

• Assessing GEN sprouting and growth using supernatants from cultured mouse podocytes.
• Inducing sublethal injury in podocytes with puromycin aminonucleoside.
• Treating injured podocytes with ARB and measuring changes in VEGF-A and Ang-1 protein levels.
• Analyzing intracellular kinase activation (p38, ERK, AKT) in GEN.

Main Results:

• Supernatant from normal podocytes enhanced GEN sprouting; injured podocyte supernatant reduced it.
• Injured podocytes showed decreased VEGF-A and Ang-1, which was reversed by ARB treatment.
• ARB-mediated recovery of GEN responses was dependent on VEGF-A and Ang-1.
• ARB treatment restored suppressed intracellular kinase activation in GEN.

Conclusions:

• Podocyte injury impairs their ability to promote GEN sprouting, a process reversible by ARB treatment.
• ARBs may mediate capillary remodeling in glomerulosclerosis by improving podocyte function.
• Targeting podocyte-specific pathways with ARBs offers a potential therapeutic strategy for kidney disease.